PAVmed (PAVM) Profit After Tax (2015 - 2025)

PAVmed's Profit After Tax history runs 11 years deep, the most recent figure standing at -$2.8 million for Q4 2025.

• On a quarterly basis, Profit After Tax rose 81.46% year-over-year to -$2.8 million in Q4 2025; TTM through Dec 2025 was -$1.8 million, a 96.04% increase from a year earlier, with the FY2025 full-year figure at -$2.5 million, down 108.69% from the prior year.
• Profit After Tax climbed to -$2.8 million in Q4 2025 per PAVM's latest filing, from -$5.4 million in the prior quarter.
• Across five years, Profit After Tax topped out at $18.6 million in Q1 2025 and bottomed at -$26.1 million in Q3 2022.
• The 5-year median for Profit After Tax is -$14.9 million (2024), against an average of -$13.3 million.
• Across the five-year window, Profit After Tax tumbled 541.08% in 2024 and soared 200.6% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$19.7 million in 2021, then fell by 3.97% to -$20.5 million in 2022, then surged by 88.66% to -$2.3 million in 2023, then tumbled by 541.08% to -$14.9 million in 2024, then jumped by 81.46% to -$2.8 million in 2025.
• Per Business Quant, the three latest PAVM Profit After Tax figures stand at -$2.8 million (Q4 2025), -$5.4 million (Q3 2025), and -$12.3 million (Q2 2025).